Flow wrappers are evolving with the times. Driving the many improvements in this area of packaging automation are the marketplace demand for more sustainable fl
The exchange of data needs to move from today’s manual processes to automated operations. Experts recap current progress, challenges, and what a “happy path” looks like.
Effective supply chain surveillance for PPE thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Thursday, April 29, 2021
Compliance with the laws and regulations enforced by the U.S. Drug Enforcement Administration (DEA) is (or should be) among the top compliance priorities for doctor’s offices, pharmacies, hospitals, and other providers that administer and dispense controlled substance medications. Non-compliance can lead to severe consequences, up to and including loss of DEA registration and the potential for criminal prosecution. But, what does it mean for health care providers to be DEA compliant in 2021?
In many respects, the obligations health care providers face today are the same as they were in 2019. While 2020 brought about unprecedented change, the oversight of health care providers’ prescription drug practices stayed largely the same. However, the DEA has issued specific guidance related to the FDA-approved COVID-19 vaccines and certain other matters related to the ongoing pandemic, and providers must heed this advice while also continuing to monito
Chronicled Announces New MediLedger Working Group To Solve Medicaid Duplicate Discounts
News provided by
Share this article
Share this article
SAN FRANCISCO, April 27, 2021 /PRNewswire/ Chronicled, administrator of the MediLedger Network (the leading blockchain-powered industry network in Life Sciences), today announced the launch of a new working group dedicated to the development of a sustainable industry solution to the problem of Medicaid duplicate discounts against 340B priced drugs. Annual spend under the 340B program has grown by 700% in the last 10 years to $35 Billion, and the number of Contract Pharmacies participating in the 340B program has grown from 1,200 to 28,000 in the same time frame. This has led to an escalating issue of manufacturers paying out Medicaid rebate claims on drugs where a 340B discount was already applied, also known as a duplicate discount. Multiple pharmaceutical manufacturers have now put in place Medicaid claim requirements and/or 340B disc